|
|
||||||||
Articles |
Division of Clinical Chemistry, Parkland Memorial Hospital, and Department of Pathology, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Dallas, TX 75235.
a Author for correspondence. Fax 214-648-2037; email jialal.i{at}pathology.swmed.edu
The purpose of this study was to evaluate the LipiDirect assay (L-LDL)
against the Direct LDLTM immunoseparation method (D-LDL)
and beta quantification (BQ-LDL) for measurement of LDL cholesterol
(LDL-C) in patients with normo- and hypertriglyceridemia. Samples from
156 patients [triglyceride (Tg) range 0.619.95 g/L] were assayed
for LDL-C concentrations with the three methods. An additional seven
patients with type III hyperlipidemia and 25 paired sera from fasting
and nonfasting individuals also were analyzed by the three
methods. Both assays displayed excellent precision. The mean
LDL-C value from L-LDL was significantly higher than BQ-LDL and D-LDL
in normo- and hypertriglyceridemic samples (P <0.001). The
mean absolute bias of L-LDL vs BQ-LDL was 12.7% for Tg <4 g/L and
30.6% for Tg
4 g/L, compared with 6.2% and 12.5%, respectively,
for D-LDL. L-LDL correctly classified only 68% of patients with LDL-C
<1.30 g/L and 57% of patients with LDL-C between 1.301.59 g/L as
compared with 98% and 93%, repectively, for D-LDL (P
<0.001). In patients with type III hyperlipidemia, L-LDL had a 130%
positive bias with BQ-LDL as compared with a 14% negative bias for
D-LDL. With all three methods there were no significant differences
between samples from fasting and nonfasting individuals. On the basis
of these findings, the D-LDL assay appears to be superior to the L-LDL
assay.
Key Words: indexing terms: coronary artery disease beta quantification hypertriglyceridemia immunoseparation
The following articles in journals at HighWire Press have cited this article:
![]() |
E. T. Bairaktari, K. I. Seferiadis, and M. S. Elisaf Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 45 - 54. [Abstract] [PDF] |
||||
![]() |
M. Nauck, G. R. Warnick, and N. Rifai Methods for Measurement of LDL-Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous Assays versus Calculation Clin. Chem., February 1, 2002; 48(2): 236 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Jialal, D. Stein, D. Balis, S. M. Grundy, B. Adams-Huet, and S. Devaraj Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels Circulation, April 17, 2001; 103(15): 1933 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Esteban-Salan, A. Guimon-Bardesi, J. M. de la Viuda-Unzueta, M. N. Azcarate-Ania, P. Pascual-Usandizaga, and E. Amoroto-Del-Rio Analytical and Clinical Evaluation of Two Homogeneous Assays for LDL-Cholesterol in Hyperlipidemic Patients Clin. Chem., August 1, 2000; 46(8): 1121 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gomez, J. Camps, J. M. Simo, N. Ferre, and J. Joven Agreement Study of Methods Based on the Elimination Principle for the Measurement of LDL- and HDL-Cholesterol Compared with Ultracentrifugation in Patients with Liver Cirrhosis Clin. Chem., August 1, 2000; 46(8): 1188 - 1191. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |